Procter Gamble (India) Performance
| PGHL Stock | 5,177 8.50 0.16% |
The company holds a Beta of 0.4, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Procter Gamble's returns are expected to increase less than the market. However, during the bear market, the loss of holding Procter Gamble is expected to be smaller as well. Procter Gamble Health right now holds a risk of 1.73%. Please check Procter Gamble Health treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to decide if Procter Gamble Health will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Procter Gamble Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Procter Gamble is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Forward Dividend Yield 0.0232 | Payout Ratio 0.7623 | Forward Dividend Rate 120 | Ex Dividend Date 2024-11-28 |
1 | Procter Gamble Health Has Announced A Dividend Of 60.00 - Simply Wall St | 09/27/2024 |
2 | Procter Gamble Health Q1 Results Live Profit Rise by 25.56 percent YOY Company Business News - Mint | 11/06/2024 |
| Begin Period Cash Flow | 4.4 B | |
| Free Cash Flow | 2.1 B |
Procter |
Procter Gamble Relative Risk vs. Return Landscape
If you would invest 516,489 in Procter Gamble Health on September 1, 2024 and sell it today you would earn a total of 1,216 from holding Procter Gamble Health or generate 0.24% return on investment over 90 days. Procter Gamble Health is generating 0.0184% of daily returns and assumes 1.7327% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Procter, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Procter Gamble Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Procter Gamble's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Procter Gamble Health, and traders can use it to determine the average amount a Procter Gamble's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0106
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PGHL |
Estimated Market Risk
| 1.73 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Procter Gamble is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Procter Gamble by adding Procter Gamble to a well-diversified portfolio.
Procter Gamble Fundamentals Growth
Procter Stock prices reflect investors' perceptions of the future prospects and financial health of Procter Gamble, and Procter Gamble fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Procter Stock performance.
| Return On Equity | 0.31 | ||||
| Return On Asset | 0.18 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 83.56 B | ||||
| Shares Outstanding | 16.6 M | ||||
| Price To Book | 15.94 X | ||||
| Price To Sales | 7.41 X | ||||
| Revenue | 11.51 B | ||||
| Gross Profit | 8.68 B | ||||
| EBITDA | 3.07 B | ||||
| Net Income | 2.01 B | ||||
| Cash And Equivalents | 3.4 B | ||||
| Total Debt | 95.6 M | ||||
| Book Value Per Share | 324.29 X | ||||
| Cash Flow From Operations | 2.28 B | ||||
| Earnings Per Share | 131.28 X | ||||
| Total Asset | 7.94 B | ||||
| Retained Earnings | 3.71 B | ||||
About Procter Gamble Performance
Assessing Procter Gamble's fundamental ratios provides investors with valuable insights into Procter Gamble's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Procter Gamble is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Procter Gamble is entity of India. It is traded as Stock on NSE exchange.Things to note about Procter Gamble Health performance evaluation
Checking the ongoing alerts about Procter Gamble for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Procter Gamble Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Procter Gamble is unlikely to experience financial distress in the next 2 years | |
| About 52.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Procter Gamble Health Q1 Results Live Profit Rise by 25.56 percent YOY Company Business News - Mint |
- Analyzing Procter Gamble's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Procter Gamble's stock is overvalued or undervalued compared to its peers.
- Examining Procter Gamble's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Procter Gamble's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Procter Gamble's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Procter Gamble's stock. These opinions can provide insight into Procter Gamble's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Procter Stock Analysis
When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.